-
At What Age Could Screening for Familial Retinoblastoma Be Stopped? Revised Dutch Retrospective Population-Based Cohort Study 1991–2019
Badalova, N. A., van Hoefen Wijsard, M., Dommering, C. J., van der Pas, S. L., Bosscha, M. I., Fabius, A. W. M. & Moll, A. C., 2025, (E-pub ahead of print) In: Ophthalmology.Research output: Contribution to journal › Article* › Academic › peer-review
-
High-Level MYCN-Amplified RB1-Proficient Retinoblastoma Tumors Retain Distinct Molecular Signatures
Roohollahi, K., de Jong, Y., van Mil, S. E., Fabius, A. W. M., Moll, A. C. & Dorsman, J. C., 1 Sept 2022, In: Ophthalmology Science. 2, 3, p. 100188 100188.Research output: Contribution to journal › Article* › Academic › peer-review
-
At What Age Could Screening for Familial Retinoblastoma Be Discontinued? A Systematic Review
van Hoefen Wijsard, M., Serné, S. H., Otten, R. H., Bosscha, M. I., Dommering, C. J., Fabius, A. W. & Moll, A. C., 2 Apr 2021, In: Cancers. 13, 8, 1942.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
